Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
EMBO Rep. 2020 Dec 3;21(12):e51034. doi: 10.15252/embr.202051034. Epub 2020 Dec 8.
Antimicrobial resistance (AMR) and persistence are associated with an elevated risk of treatment failure and relapsing infections. They are thus important drivers of increased morbidity and mortality rates resulting in growing healthcare costs. Antibiotic resistance is readily identifiable with standard microbiological assays, and the threat imposed by antibiotic resistance has been well recognized. Measures aiming to reduce resistance development and spreading of resistant bacteria are being enforced. However, the phenomenon of bacteria surviving antibiotic exposure despite being fully susceptible, so-called antibiotic persistence, is still largely underestimated. In contrast to antibiotic resistance, antibiotic persistence is difficult to measure and therefore often missed, potentially leading to treatment failures. In this review, we focus on bacterial mechanisms allowing evasion of antibiotic killing and discuss their implications on human health. We describe the relationship between antibiotic persistence and bacterial heterogeneity and discuss recent studies that link bacterial persistence and tolerance with the evolution of antibiotic resistance. Finally, we review persister detection methods, novel strategies aiming at eradicating bacterial persisters and the latest advances in the development of new antibiotics.
抗菌药物耐药性(AMR)和持久性与治疗失败和复发感染的风险增加有关。因此,它们是导致发病率和死亡率上升、医疗保健成本不断增加的重要驱动因素。抗生素耐药性可以通过标准的微生物检测来识别,抗生素耐药性带来的威胁已经得到充分认识。目前正在采取措施来减少耐药性的发展和耐药菌的传播。然而,尽管细菌完全敏感,但仍能在抗生素暴露下存活的现象,即所谓的抗生素持久性,仍在很大程度上被低估。与抗生素耐药性不同,抗生素持久性难以测量,因此经常被忽视,这可能导致治疗失败。在这篇综述中,我们重点关注细菌逃避抗生素杀伤的机制,并讨论它们对人类健康的影响。我们描述了抗生素持久性与细菌异质性之间的关系,并讨论了将细菌持久性和耐受性与抗生素耐药性进化联系起来的最新研究。最后,我们综述了检测细菌持久性的方法、旨在消除细菌持久性的新策略以及新抗生素开发的最新进展。